RPHM Reneo Pharmaceuticals Inc
681
$1.73
$0.01
(0.57%)
| Watchers | 681 |
| 52-Wk Low | $0.9801 |
| 52-Wk High | $9.45 |
| Market Cap | $57.82M |
| Volume | 402.00 |
| 52-Wk High | $9.45 |
| 52-Wk Low | $0.9801 |
Sell Rating on Reneo Pharmaceuticals Amid Strategic Uncertainty and Reduced Price TargetTipRanks Financial Blog • about 1 month ago
Reneo Pharmaceuticals (RPHM Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on March 28. Analyst Jason Ze...
Share to Feed
IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a pharmaceutical company historically focused on the development and commercialization of therapies...
Reneo Pharmaceuticals GAAP EPS of -$2.52...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
RPHM stock results show that Reneo Pharmaceuticals missed analyst estimates for earnings per share the fourth quarter of 2023.
The post...
SAN MATEO, Calif., March 25, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN...
Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM Get Free Report) has received an average recommendation of Reduce from the eight research firms that are covering the firm, MarketBeat...
Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM Get Free Report) has earned an average rating of Reduce from the eight research firms that are presently covering the company...
Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM Get Free Report) was the target of a significant decrease in short interest in January. As of January 15th, there was short interest totalling...